Sp1 and Sp3 regulate basal transcription of the survivin gene.
about
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressivenessSurvivin - biology and potential as a therapeutic target in oncologyAntitumorigenic effect of atmospheric-pressure dielectric barrier discharge on human colorectal cancer cells via regulation of Sp1 transcription factor.Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.Activity of the upstream component of tandem TERT/survivin promoters depends on features of the downstream component.Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behaviorSignificant biological role of sp1 transactivation in multiple myelomaHCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of SurvivinEsculetin, a Coumarin Derivative, Exhibits Anti-proliferative and Pro-apoptotic Activity in G361 Human Malignant Melanoma.Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.The twisted survivin connection to angiogenesisSurvivin, a novel target of the Hedgehog/GLI signaling pathway in human tumor cellsCombination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen speciesSmall molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distributionTherapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct.Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effectTumour-specific triple-regulated oncolytic herpes virus to target glioma.Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell.Transcriptional regulation of the survivin gene.Survivin as a preferential target for cancer therapy.Sp1 and the 'hallmarks of cancer'.Selective estrogen receptor modulators and betulinic acid act synergistically to target ERα and SP1 transcription factor dependent Pygopus expression in breast cancer.Anti-proliferative properties of kahweol in oral squamous cancer through the regulation specificity protein 1.Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.Anti-leukemic response of a NSAID, tolfenamic acid.Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.Sp1 upregulates survivin expression in adenocarcinoma of lung cell line A549.Chemostat-based transcriptional analysis of growth rate change and BCL-2 over-expression in NS0 cells.Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax.Epigenetic mechanism of survivin dysregulation in human cancer.Caspase cleavage of transcription factor Sp1 enhances apoptosis.HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer.
P2860
Q21143866-D04E19C6-663B-4682-BABF-50ED7851700DQ26864567-11824893-34D0-47A4-9BBD-7CFFCFB89403Q33469868-21660FA2-D640-4898-B272-F8E6D40248D9Q33864137-199F6A99-C767-4CFB-8FB5-9282928C780AQ34441503-22930BDF-A4EB-4B35-A35B-961F215CB19BQ34592780-4466A326-659F-4604-B217-9AB791B9FE99Q35052959-919AEF5D-E383-47C4-A882-0F2D7227946BQ35568782-8A3B6FCA-8E8E-4F59-A023-A5943A078B52Q35745202-4B824726-5DD3-47B1-A307-D0E9CF3B7E6EQ35820967-37921431-8933-40B0-9740-F591B947A1ADQ36073279-3D979A50-228C-4981-A8F8-731F5E47D7E6Q36301932-5F3EAE95-1661-4BDC-A2E2-E9DF51772E21Q36751735-4CB3A7E5-E6DD-4CF8-ADEE-8E8E749B2C75Q36772076-9E94AF63-5090-401B-AF2B-7DCF3FC13C2AQ36880450-34AF7FA2-0605-4187-B1D1-09A98DBE0F1EQ36984046-9FFE72C7-59D0-4702-A524-DF50F964BA9BQ37134443-C55A46A4-A86E-4511-A924-E239AEEB3889Q37295187-3316F076-E48B-434D-BA45-D85EFB12C889Q37317636-FE231E92-62B2-4E4F-846A-3975DFE66FA6Q37335425-2F001152-4EEB-4F17-8B55-441D46C9420DQ38160371-2B531763-78CB-4F01-ADBA-A1D80B2588F0Q38188377-44E30CA2-D36C-4F52-808C-0FEFCE84CBDDQ38267908-07BD94FF-63EA-4B02-98C2-B5E31DC8D76EQ38813726-1EBDCCE3-CE04-4D84-896D-C18062E8BC4CQ38958948-35EECBB2-F82C-4F06-A517-35D4399665D7Q39149869-70AE5811-0F4C-4D94-BEDF-E57DBF1A256FQ39162217-2DFCDB35-3ECF-46C7-93EC-8DF0EB029C14Q39290326-E6F3BB4A-336C-46D7-A915-4C305036C36FQ39369722-60F9EC94-A72F-4466-BA3E-77D99B2538B7Q39418496-CDCFC360-A38C-4DD2-B8BD-DB6A2E4E566CQ39571381-A4C1E007-061A-4E69-A3AC-7CBDCAEBC65BQ39588832-AB907125-A75D-4938-B94F-6FD4179195ECQ44584047-F59B29B1-96C7-4015-8FFB-DBB589CCABD4Q47215045-D06F72B0-A659-416E-867B-57E10F2A8414Q47298461-02E9A494-7DA7-4327-AB03-A9A3472CEBA1Q49283314-65D91B94-6CFB-455D-8D65-6D03B6D2447BQ52725329-5192D17D-04D0-4525-975F-21CFDD6C0D06
P2860
Sp1 and Sp3 regulate basal transcription of the survivin gene.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sp1 and Sp3 regulate basal transcription of the survivin gene.
@en
type
label
Sp1 and Sp3 regulate basal transcription of the survivin gene.
@en
prefLabel
Sp1 and Sp3 regulate basal transcription of the survivin gene.
@en
P2093
P1476
Sp1 and Sp3 regulate basal transcription of the survivin gene.
@en
P2093
GuanXiang Qian
Jian Huang
Ping Zhang
ShengFang Ge
P304
P356
10.1016/J.BBRC.2007.02.140
P407
P577
2007-03-05T00:00:00Z